Lung: Lymphoma: Hodgkin's Regimens

DISEASE: Lymphoma: Hodgkin's

Select a REGIMEN:

DISEASE: Lymphona: Hodgkins

REGIMEN: ABVD

DOXORUBICIN [DOX] 25 mg/m2 IV...D1,14
Caution: Monitor cumulative dose (cardiac toxicity)

BLEOMYCIN [BLEO] 10 units/m2 IV...D1,14
Caution: Monitor cumulative dose (pulmonary toxicity)

VINBLASTINE [VLB] 6 mg/m2 IV...D1,14

DACARBAZINE [DTIC] 150 mg/m2 IV... D1-5

CYCLE: 28 days for 6 cycles
REFER: Bonadonna G, et al: CANCER 1975; 36:252-259.

DISEASE: Lymphoma: Hodgkin's

REGIMEN: BCVPP

CARMUSTINE [BCNU] 100 mg/m2 IV... D1
Caution: Monitor cumulative dose (pulmonary and marrow toxicity)

VINBLASTINE [VLB] 5 mg/m2 IV... D1

CYCLOPHOSPHAMIDE [CTX] 600 mg/m2 IV... D1

PROCARBAZINE [PCB] 50 mg/m2 PO... D1
1st day only

PROCARBAZINE [PCB] 100 mg/m2 per day PO... D2-10
After 1st day

PREDNISONE[Pred] 60 mg/m2 per day PO... D1-10

CYCLE: 28 days
REFER: Bakemeier RF, et al: ANN INTERN MED 1984; 101:447-456.

DISEASE: Lymphoma: Hodgkin's

REGIMEN: EVA

ETOPOSIDE

VINBLASTINE [VLB] 6 mg/m2 IV... D1

DOXORUBICIN [DOX] 50 mg/m2 IV... D1
Caution: Monitor cumulative dose (cardiac toxicity)

CYCLE: 28 days for 6 cycles
REFER: Canellos GP, et al: PROC ASCO 1991; 10:273.

DISEASE: Lymphoma: Hodgkin's

REGIMEN: MOPP

MECHLORETHAMINE

VINCRISTINE [VCR] 1.4 mg/m2 IV... D1,8
(No cap at 2 mg)

PROCARBAZINE [PCB] 100 mg/m2 per day PO... D1-14

PREDNISONE [Pred] 40 mg/m2 per day PO... D1-14

CYCLE: 28 days
REFER: DeVita VT, et al: PPO UPDATES 1993; 7:1-11.

DISEASE: Lymphoma: Hodgkin's

REGIMEN: MOPP/ABV

MECHLORETHAMINE

VINCRISTINE [VCR] 1.4 mg/m2 IV... D1

PROCARBAZINE [PCB] 100 mg/m2 per day PO... D1-7

PREDNISONE [Pred] 40 mg/m2 per day PO... D1-14

DOXORUBICIN [DOX] 35 mg/m2 IV... D8
Caution: Monitor cumulative dose (cardiac toxicity)

BLEOMYCIN [BLEO] 10 units/m2 IV... D8
Caution: Monitor cumulative dose (pulmonary toxicity)

VINBLASTINE [VLB] 6 mg/m2 IV... D8

CYCLE: 28 days
REFER: Connors JM, et al: PROC ASCO 1992; 11:317.

Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service.

Please read the Disclaimer of Warranties before using information contained in this section.